I know we have our priorities straight when we cancel Grand Rounds for the entire department so we can watch this instead 😂 Dr. Glaucomflecken

Experts from OU Health Stephenson Cancer Center are attending ASCO's conference this week. With more than 200 sessions this event is a unique opportunity for international cancer experts to see latest innovations in cancer research and education. #ASCO23 linkedin.com/feed/update/ur…

Susanna Ulahannan, M.D., presenting “A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.” ascopubs.org/doi/abs/10.120… #ASCO23

Susanna Ulahannan, M.D., presenting: “Preliminary results from ERAS-007 plus palbociclib (palbo) in patients (pts) with KRAS/NRAS mutant (m) colorectal cancer (CRC) or KRASm pancreatic ductal adenocarcinoma (PDAC) in HERKULES-3 study.” ascopubs.org/doi/abs/10.120… #ASCO23

Cannabis use among adults undergoing #cancer treatment. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… ACS Journal Cancer OU Health Stephenson Cancer Center Desiree Azizoddin, PsyD Christina Henson, MD Susanna Ulahannan MD OU Health OU DOM Resident Research #cannabisnews #PallOnc #SuppOnc

“Research 101: Designing Your First Clinical Trial” Don’t miss our panel on Sunday 6/2 from 11:00-11:45AM at #ASCO2024 Dana-Farber’s Breast Oncology Center ASCO ASCO TECAG OncoAlert

Starting soon (in 7 minutes) in the Trainee and Early Career Lounge!! #RadOnc #ASCO24

Excellent panel discussion at #ASCO24 on strategies for designing clinical trials featuring #RadOnc superstar Shearwood McClelland III, M.D. and other excellent #oncology researchers and clinicians. I love the #EarlyCareer focused programming available at ASCO meetings and having a dedicated lounge

These panelists were such ⭐️rockstars⭐️ and did an amazing job speaking about #clinicaltrials, everyone wanted to talk to them more after the session ended! ASCO TECAG #ASCO24

Another event ASCO TECAG was the “Designing Your First Clinical Trial” with Guilherme Nader Marta Linda Vahdat Shearwood McClelland III, M.D. and Dr. Ulahannan. Very exciting to hear perspectives on what is the best way to achieve grants, being resourceful and most importantly a team-player. #ASCO24

#asco24 TEC sessions never fail to impress Susanna Ulahannan MD amongst 🌟 panel discussing “Designing Your First Clinical Trial” ASCO TECAG OU DOM Resident Research

Great talk on designing your first clinical trial ASCO TECAG by Guilherme Nader Marta ,Linda Vahdat Shearwood McClelland III, M.D. and Susanna Ulahannan MD. Thank you for answering my questions.

First Results of STELLA Study: ART0380 (an ATR Kinase Inhibitor) With Low Dose Irinotecan in Advanced or Metastatic Solid Tumors | VuMedi vumedi.com/video/first-re… via @vumedi